Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07126132Completed

Hpx•apoB Product as a Biomarker for Coronary Artery Disease

Role: lead

NCT07091266Not ApplicableCompleted

SNM vs. HBOT for Refractory IC/BPS

Role: lead

NCT07074834Not ApplicableCompleted

Metoprolol and Trimetazidine for Coronary Heart Disease With Angina

Role: lead

NCT07055035Not ApplicableCompleted

Atrial Synchrony Evaluation of Bachmann Bundle Pacing in Sick Sinus Syndrome

Role: lead

NCT05701449Unknown

Prevention and Treatment of Perioperative Lung Injury in Elderly Patients

Role: collaborator

All 5 trials loaded